Tissue-resident memory cells in antitumoral immunity and cancer immunotherapy. Review uri icon

Overview

abstract

  • As cancer immunotherapy evolves, tissue-resident memory (TRM) cells remain key contributors to the antitumoral immune response due to their ability to mediate local tumor control, high expression of immune checkpoints, potential to respond to immunotherapy, and location across tissue sites where distal tumor metastases occur. This review synthesizes recent findings on the biology of TRM cells, their role in cancer, and their interactions with the tumor microenvironment. We also identify several critical research gaps, such as how mechanistic interrogation of TRM cell function is required for integration into therapeutics, proposing a focused research agenda to better exploit their potential.

publication date

  • October 31, 2024

Research

keywords

  • Immunologic Memory
  • Immunotherapy
  • Neoplasms
  • Tumor Microenvironment

Identity

Digital Object Identifier (DOI)

  • 10.1016/j.coi.2024.102499

PubMed ID

  • 39486215

Additional Document Info

volume

  • 91